Title:
ANTI-PROTEIN C ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2019/009407
Kind Code:
A1
Abstract:
The problem addressed by the present invention is to provide a novel drug for treating haemorrhagic disorders which has a superior blood-coagulating effect, and a method for treating haemorrhagic disorders which uses said drug. Provided are: an antibody which bonds to both Protein C and activated-Protein C, and inhibits Protein C activation and activated-Protein C activity; an antigen-binding fragment of said antibody; a chimeric antibody of said antibody; a pharmaceutical compound comprising said antibody; and the like.
Inventors:
FURUGORI TAKETOSHI (JP)
NAKAMURA KENSUKE (JP)
NAKAMURA KENSUKE (JP)
Application Number:
PCT/JP2018/025679
Publication Date:
January 10, 2019
Filing Date:
July 06, 2018
Export Citation:
Assignee:
DAIICHI SANKYO CO LTD (JP)
International Classes:
C12N15/06; A61K39/395; A61P7/04; C07K16/18; C12N1/15; C12N1/19; C12N5/10; C12P21/08
Domestic Patent References:
| WO2015041310A1 | 2015-03-26 | |||
| WO2009055669A2 | 2009-04-30 |
Foreign References:
| JPH0638743A | 1994-02-15 |
Attorney, Agent or Firm:
ISHIBASHI Koki et al. (JP)
Download PDF: